Search

everythinglearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

OsPHR2 gene in rice enhances root growth and phosphorus accumulation.

Microneedles are promising for disease monitoring and drug delivery due to their minimal invasiveness and versatility.

Microvascular damage and platelet issues persist in ulcerative colitis remission, helping assess disease states.

Microneedles improve delivery of plant-based compounds through the skin, aiding treatments for hair loss, cancer, and wounds.

Caffeine can boost health but may cause side effects like high blood pressure and migraines.

PHAs are promising biodegradable materials for medical and dental uses.

Sex-limited chromosomes can affect traits not related to reproduction.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Ritlecitinib is safe and may effectively treat alopecia areata.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Ginsenoside Rg4 from ginseng may help hair growth by activating certain cell signals.

Red and near-infrared light-emitting fabric may help improve psoriasis, PMLE, and alopecia areata.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Baricitinib is effective and safe for treating alopecia areata in Korea.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Severe genetic variants in children with a specific adrenal condition match predicted symptoms well, but milder variants do not.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.